SAREPTA THERAPEUTICS, INC. logo

SAREPTA THERAPEUTICS, INC.

109 Marks
Corp.
First Filed:Apr 27, 1992Latest Filed:Oct 21, 2025Address:215 First Street, 4th Floor, Cambridge, MA 02142, US

Portfolio Overview

Registered
42(39%)
Pending
9(8%)
Dead
58(53%)

Top Classes

Class 5
Pharmaceuticals
71(65%)
Class 44
Medical, beauty and agricultural services
22(20%)
Class 42
Software, IT Services & Scientific Research
11(10%)

TTAB Proceedings

Total Proceedings
7
As Plaintiff
2(29%)
As Defendant
5(71%)

Top Firms

Tepper & Eyster, PLLC(Oct 2025)
66
ARNOLD & PORTER KAYE SCHOLER...(Apr 2025)
42

Trademark Activity Timeline(1992 – 2025)

Trademark Portfolio

109 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
LYMDEVRA
LYMDEVRA
Trademark
Word
PENDING
Owner:
Serial:99454183
Filed:Oct 21, 2025
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations containing viral vectors for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations for gene therapy, gene editing, and genome editing for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Gene therapies, in the nature of pharmaceutical preparations, for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
BELYMGO
BELYMGO
Trademark
Word
ABANDONED
Owner:
Serial:99250696
Filed:Jun 24, 2025
Classes:5
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations containing viral vectors for neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations for gene therapy, gene editing, and genome editing for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Gene therapies, in the nature of pharmaceuticals, for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
RYSBEVI
RYSBEVI
Trademark
Word
PENDING
Owner:
Serial:99249858
Filed:Jun 24, 2025
Classes:5
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations containing viral vectors for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations for gene therapy, gene editing, and genome editing for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Gene therapies, in the nature of pharmaceuticals, for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
SAREPTACADEMY
SAREPTACADEMY
Service Mark
Word
PENDING
Owner:
Serial:99119415
Filed:Apr 3, 2025
Classes:42, 44
Goods & Services
Medical information services, namely, providing information relating to rare diseases, medicines, health conditions, and treatment options; Providing online health information for patients and families of patients via non-downloadable videos; Medical information services provided via the Internet; Providing health information; Providing healthcare information; Providing medical information; Providing a web site featuring medical information; Providing medical information in the field of rare diseases, genetic diseases and disorders, muscular dystrophies, gene therapy products, genetic medicines, PMOs, and RNA-based and RNAi-based therapies; Providing medical information to patients, caregivers, families, and healthcare professionals in the form of reports in the field of navigating a rare disease diagnosis and exploring existing and potential treatment options for rare diseases and genetic diseases and disorders; Providing information about genetic testing for medical purposes; Providing educational information about healthcare; Providing information about medical and healthcare research and clinical trials; Providing information to healthcare providers and patients about medical and healthcare research and clinical trials; Providing medical and scientific research information; Providing information about medical and scientific research; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the field of clinical trials; Providing medical research information in the field of rare diseases genetic diseases and disorders, muscular dystrophies, gene therapy products, genetic medicines, PMOs, and RNA-based and RNAi-based therapies; Providing scientific research information in the field of rare diseases genetic diseases and disorders, muscular dystrophies, gene therapy products, genetic medicines, PMOs, and RNA-based and RNAi-based therapies; Medical and scientific research information in the field of rare diseases genetic diseases and disorders, muscular dystrophies, gene therapy products, genetic medicines, PMOs, and RNA-based and RNAi-based therapies; Providing information on clinical studies via an interactive website; Providing information in the field of clinical research via a website; Providing a website featuring educational information in the field of clinical research
BETRUVO
BETRUVO
Trademark
Word
ABANDONED
Owner:
Serial:98771029
Filed:Sep 26, 2024
Classes:5, 41, 44
Goods & Services
Medical training and teaching; Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases; Medical services; providing health information
BEVALTI
BEVALTI
Trademark
Word
ABANDONED
Owner:
Serial:98771026
Filed:Sep 26, 2024
Classes:5, 41, 44
Goods & Services
Medical training and teaching; Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases; Medical services; providing health information
ELYMBI
ELYMBI
Trademark
Word
ABANDONED
Owner:
Serial:98771024
Filed:Sep 26, 2024
Classes:5, 41, 44
Goods & Services
Medical training and teaching; Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations for gene therapy, gene editing, and genome editing for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Gene therapies, in the nature of pharmaceuticals, for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations containing viral vectors for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases; Medical services; providing health information
98757000
98757000
Trademark
Design
PENDING
Owner:
Serial:98757000
Filed:Sep 18, 2024
Classes:1, 5, 11, +2
Goods & Services
Medical training and teaching; Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations for gene therapy, gene editing, and genome editing for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Gene therapies, in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viral vaccines and viral vectors vaccines for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases; Viruses, viral vectors, and viral constructs for use in the manufacture of pharmaceuticals for the treatment of neuromuscular diseases and disorders.; Medical services; providing health information
MYOPEPDYS (VESLETEPLIRSEN) INJECTION
MYOPEPDYS (VESLETEPLIRSEN) INJECTION
Trademark
Combined
ABANDONED
Owner:
Serial:98370905
Filed:Jan 23, 2024
Classes:5, 41, 44
Goods & Services
Medical training and teaching; Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases; Medical services; providing health information; "VESLETEPLIRSEN INJECTION"
EVOMYO
EVOMYO
Trademark
Word
PENDING
Owner:
Serial:98040253
Filed:Jun 13, 2023
Classes:5
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs being pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
SAREPTA EXCHANGE
SAREPTA EXCHANGE
Service Mark
Word
PENDING
Owner:
Serial:98012837
Filed:May 25, 2023
Classes:35
Goods & Services
Connecting healthcare providers with medical specialists and researchers to enable communication and consultation regarding health and medical treatment issues; Providing connections in the nature of connecting healthcare providers, medical specialists and researchers in the field of health care for treatment of rare diseases; Connecting physicians and medical specialists; Connections in the field of healthcare, namely, connecting healthcare providers, medical specialists and researchers
SAREPTA EXCHANGE
SAREPTA EXCHANGE
Service Mark
Combined
PENDING
Owner:
Serial:98012839
Filed:May 25, 2023
Classes:35
Goods & Services
Connecting healthcare providers with medical specialists and researchers to enable communication and consultation regarding health and medical treatment issues; Providing connections in the nature of connecting healthcare providers, medical specialists and researchers in the field of health care for treatment of rare diseases; Connecting physicians and medical specialists; Connections in the field of healthcare, namely, connecting healthcare providers, medical specialists and researchers
ELEVIDYS
ELEVIDYS
Trademark
Combined
PENDING
Owner:
Serial:97925396
Filed:May 8, 2023
Classes:5
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs being pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
ELEVIDYS
ELEVIDYS
Trademark
Combined
ABANDONED
Owner:
Serial:97923896
Filed:May 6, 2023
Classes:5
ALDYSTRO
ALDYSTRO
Trademark
Word
PENDING
Owner:
Serial:97368281
Filed:Apr 18, 2022
Classes:5
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
EVOMYO
EVOMYO
Trademark
Word
ABANDONED
Owner:
Serial:97368273
Filed:Apr 18, 2022
Classes:5
EVOPEPDYS
EVOPEPDYS
Trademark
Word
ABANDONED
Owner:
Serial:97368267
Filed:Apr 18, 2022
Classes:5
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
MYOPEPDYS
MYOPEPDYS
Trademark
Word
ABANDONED
Owner:
Serial:97368285
Filed:Apr 18, 2022
Classes:5
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
S
S
Service Mark
Combined
REGISTERED
Owner:
Serial:97243311
Filed:Jan 28, 2022
Classes:44
Registration:7063684
Registered:May 23, 2023
Goods & Services
Providing health information; Providing health information in the field of muscular dystrophy, Duchenne muscular dystrophy, and rare diseases; Providing health information for patients and families of patients in the field of living with muscular dystrophy, Duchenne muscular dystrophy, and rare diseases; Providing online health information for patients and families of patients via non-downloadable videos; Medical information services, namely, providing information relating to rare diseases, and health conditions; Provision of health care services, namely, providing information to patients regarding rare diseases, and health conditions | Providing personal support services for patients and families of patients in the nature of organizing and conducting support groups in the field of emotional support and the field of living with muscular dystrophy, Duchenne muscular dystrophy, and rare diseases; Providing online and in-person social networking services; Providing online social networking services and organizing and conducting support groups for patients and families of patients with muscular dystrophy, Duchenne muscular dystrophy, and rare diseases; Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support; Providing information regarding community emotional support resources and support groups
SAREPTACIRCLE
SAREPTACIRCLE
Service Mark
Word
REGISTERED
Owner:
Serial:97243301
Filed:Jan 28, 2022
Classes:44
Registration:7063683
Registered:May 23, 2023
Goods & Services
Providing health information; Providing health information in the field of muscular dystrophy, Duchenne muscular dystrophy, and rare diseases; Providing health information for patients and families of patients in the field of living with muscular dystrophy, Duchenne muscular dystrophy, and rare diseases; Providing online health information for patients and families of patients via non-downloadable videos; Medical information services, namely, providing information relating to rare diseases, and health conditions; Provision of health care services, namely, providing information to patients regarding rare diseases, and health conditions | Providing personal support services for patients and families of patients in the nature of organizing and conducting support groups in the field of emotional support and the field of living with muscular dystrophy, Duchenne muscular dystrophy, and rare diseases; Providing online and in-person social networking services; Providing online social networking services and organizing and conducting support groups for patients and families of patients with muscular dystrophy, Duchenne muscular dystrophy, and rare diseases; Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support; Providing information regarding community emotional support resources and support groups
90857997
90857997
Service Mark
Design
REGISTERED
Owner:
Serial:90857997
Filed:Jul 30, 2021
Classes:44
Registration:7243420
Registered:Dec 12, 2023
Goods & Services
Providing health information
90857995
90857995
Trademark
Design
REGISTERED
Owner:
Serial:90857995
Filed:Jul 30, 2021
Classes:5
Registration:7243419
Registered:Dec 12, 2023
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders
EXONDYS 51 (ETEPLIRSEN)
EXONDYS 51 (ETEPLIRSEN)
Service Mark
Combined
REGISTERED
Owner:
Serial:90857985
Filed:Jul 30, 2021
Classes:44
Registration:7158274
Registered:Sep 5, 2023
Goods & Services
"51" AND "ETEPLIRSEN"
EXONDYS 51 (ETEPLIRSEN)
EXONDYS 51 (ETEPLIRSEN)
Trademark
Combined
REGISTERED
Owner:
Serial:90857980
Filed:Jul 30, 2021
Classes:5
Registration:7032061
Registered:Apr 18, 2023
Goods & Services
"51" AND "ETEPLIRSEN"
VYONDYS 53 (GOLODIRSEN)
VYONDYS 53 (GOLODIRSEN)
Trademark
Combined
REGISTERED
Owner:
Serial:90857988
Filed:Jul 30, 2021
Classes:5
Registration:7190346
Registered:Oct 10, 2023
Goods & Services
"53" AND "GOLODIRSEN"
VYONDYS 53 (GOLODIRSEN)
VYONDYS 53 (GOLODIRSEN)
Service Mark
Combined
REGISTERED
Owner:
Serial:90857991
Filed:Jul 30, 2021
Classes:44
Registration:6951341
Registered:Jan 10, 2023
Goods & Services
"53" AND "GOLODIRSEN"
SAREPTALLY
SAREPTALLY
Service Mark
Combined
REGISTERED
Owner:
Serial:90736299
Filed:May 26, 2021
Classes:42
Registration:7081468
Registered:Jun 13, 2023
Goods & Services
Providing information about medical and healthcare research and clinical trials; providing information to healthcare providers and patients about medical and healthcare research and clinical trials | Providing prescription pharmaceuticals through early access pathways in the nature of a patient assistance program to provide drugs to eligible patients; providing information about access to medical treatments and services; counselling services, namely, providing information and counselling with respect to access to medical treatment and care; providing health information; Providing access to pharmaceuticals in the nature of a patient assistance program to provide drugs to eligible patients; providing information to healthcare providers and patients about medication, access to medical treatment and care, and local pathways for access to medical treatment and care
SAREPTALLY
SAREPTALLY
Service Mark
Word
REGISTERED
Owner:
Serial:90735657
Filed:May 26, 2021
Classes:42
Registration:7081466
Registered:Jun 13, 2023
Goods & Services
Providing information about medical and healthcare research and clinical trials; providing information to healthcare providers and patients about medical and healthcare research and clinical trials | Providing prescription pharmaceuticals through early access pathways in the nature of a patient assistance program to provide drugs to eligible patients; providing information about access to medical treatments and services; counselling services, namely, providing information and counselling with respect to access to medical treatment and care; providing health information; Providing access to pharmaceuticals in the nature of a patient assistance program to provide drugs to eligible patients; providing information to healthcare providers and patients about medication, access to medical treatment and care, and local pathways for access to medical treatment and care
MYOLIVITY
MYOLIVITY
Trademark
Word
ABANDONED
Owner:
Serial:90726719
Filed:May 21, 2021
Classes:5
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products, namely, pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
MYOTRUVI
MYOTRUVI
Trademark
Word
ABANDONED
Owner:
Serial:90726726
Filed:May 21, 2021
Classes:5
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products, namely, pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
AMONDYS 45 (CASIMERSEN)
AMONDYS 45 (CASIMERSEN)
Trademark
Combined
REGISTERED
Owner:
Serial:90458567
Filed:Jan 11, 2021
Classes:5
Registration:6564415
Registered:Nov 16, 2021
Goods & Services
"45 (CASIMERSEN)"
AMONDYS 45 (CASIMERSEN)
AMONDYS 45 (CASIMERSEN)
Service Mark
Combined
REGISTERED
Owner:
Serial:90458549
Filed:Jan 11, 2021
Classes:44
Registration:7043671
Registered:May 2, 2023
Goods & Services
"45 (CASIMERSEN)"
SANGEXYS
SANGEXYS
Trademark
Word
ABANDONED
Owner:
Serial:90391430
Filed:Dec 17, 2020
Classes:5
GENZELENT
GENZELENT
Trademark
Word
ABANDONED
Owner:
Serial:90382660
Filed:Dec 15, 2020
Classes:5
SANGENTRI
SANGENTRI
Trademark
Word
ABANDONED
Owner:
Serial:90382648
Filed:Dec 15, 2020
Classes:5
SANGENZA
SANGENZA
Trademark
Word
ABANDONED
Owner:
Serial:90382655
Filed:Dec 15, 2020
Classes:5
SANTRUVO
SANTRUVO
Trademark
Word
ABANDONED
Owner:
Serial:90382653
Filed:Dec 15, 2020
Classes:5
90369574
90369574
Trademark
Design
ABANDONED
Owner:
Serial:90369574
Filed:Dec 9, 2020
Classes:16
TRIGENESIS
TRIGENESIS
Trademark
Combined
ABANDONED
Owner:
Serial:90369578
Filed:Dec 9, 2020
Classes:16
AMONDYS 45
AMONDYS 45
Trademark
Word
REGISTERED
Owner:
Serial:90135119
Filed:Aug 25, 2020
Classes:5
Registration:6570569
Registered:Nov 23, 2021
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders
90051522
90051522
Trademark
Design
REGISTERED
Owner:
Serial:90051522
Filed:Jul 14, 2020
Classes:9
Registration:7019427
Registered:Apr 4, 2023
Goods & Services
Downloadable curricula, lesson plans, lessons, handouts, activity sheets, assessments, and educational materials in the fields of health, chronic diseases and living with chronic diseases
RARE LESSONS
RARE LESSONS
Trademark
Word
REGISTERED
Owner:
Serial:90051539
Filed:Jul 14, 2020
Classes:9
Registration:7019428
Registered:Apr 4, 2023
Goods & Services
Downloadable curricula, lesson plans, lessons, handouts, activity sheets, assessments, and educational materials in the fields of health, chronic diseases and living with chronic diseases | Educational services, namely, arranging for the development and dissemination of educational materials in the fields of health, healthcare and diseases; Educational services, namely, arranging for the development and dissemination of educational materials in the field of inclusivity and community building within the classroom and the community; Educational services, namely, arranging for the development and dissemination of educational materials in the field of inclusivity and community building for children and other persons living with chronic diseases
MYOSTRADA
MYOSTRADA
Trademark
Word
ABANDONED
Owner:
Serial:88895910
Filed:Apr 30, 2020
Classes:5
DUCEMMA
DUCEMMA
Trademark
Word
ABANDONED
Owner:
Serial:88886727
Filed:Apr 24, 2020
Classes:5
DYSBRAVA
DYSBRAVA
Trademark
Word
ABANDONED
Owner:
Serial:88886735
Filed:Apr 24, 2020
Classes:5
DYSTAVIO
DYSTAVIO
Trademark
Word
ABANDONED
Owner:
Serial:88886703
Filed:Apr 24, 2020
Classes:5
DYSTRIFY
DYSTRIFY
Trademark
Word
ABANDONED
Owner:
Serial:88886707
Filed:Apr 24, 2020
Classes:5
ELEVIDYS
ELEVIDYS
Trademark
Word
REGISTERED
Owner:
Serial:88886693
Filed:Apr 24, 2020
Classes:5
Registration:7037471
Registered:Apr 25, 2023
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
MYOGENDYS
MYOGENDYS
Trademark
Word
ABANDONED
Owner:
Serial:88886717
Filed:Apr 24, 2020
Classes:5
88829932
88829932
Trademark
Design
REGISTERED
Owner:
Serial:88829932
Filed:Mar 11, 2020
Classes:5
Registration:6918743
Registered:Dec 6, 2022
Goods & Services
pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
88829952
88829952
Service Mark
Design
REGISTERED
Owner:
Serial:88829952
Filed:Mar 11, 2020
Classes:42
Registration:6713848
Registered:Apr 26, 2022
Goods & Services
medical and scientific research services, namely, medical research; medical and scientific research services all in the field of rare and infectious diseases; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies
88829946
88829946
Trademark
Design
ABANDONED
Owner:
Serial:88829946
Filed:Mar 11, 2020
Classes:1
88829938
88829938
Service Mark
Design
REGISTERED
Owner:
Serial:88829938
Filed:Mar 11, 2020
Classes:44
Registration:7012841
Registered:Mar 28, 2023
Goods & Services
medical information services, namely, providing information relating to rare diseases, medicines, health conditions, and treatment options; Provision of health care services, namely, providing information to doctors and patients regarding rare diseases, medicines, health conditions and treatment options
TRIGENESIS
TRIGENESIS
Trademark
Word
ABANDONED
Owner:
Serial:88811637
Filed:Feb 26, 2020
Classes:5
VYONDYS 53 (GOLODIRSEN) INJECTION
VYONDYS 53 (GOLODIRSEN) INJECTION
Service Mark
Combined
REGISTERED
Owner:
Serial:88756745
Filed:Jan 13, 2020
Classes:44
Registration:6241366
Registered:Jan 5, 2021
Goods & Services
"53 (GOLODIRSEN) INJECTION"
VYONDYS 53 (GOLODIRSEN) INJECTION
VYONDYS 53 (GOLODIRSEN) INJECTION
Trademark
Combined
REGISTERED
Owner:
Serial:88726918
Filed:Dec 13, 2019
Classes:5
Registration:6241288
Registered:Jan 5, 2021
Goods & Services
"53 (GOLODIRSEN) INJECTION"
VYONDYS 53
VYONDYS 53
Trademark
Word
REGISTERED
Owner:
Serial:88569849
Filed:Aug 7, 2019
Classes:5
Registration:6240773
Registered:Jan 5, 2021
Goods & Services
"53"
AMONDYS
AMONDYS
Trademark
Word
REGISTERED
Owner:
Serial:88559700
Filed:Aug 1, 2019
Classes:5
Registration:6548209
Registered:Nov 2, 2021
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders
EXCLOVIS
EXCLOVIS
Trademark
Word
ABANDONED
Owner:
Serial:88559688
Filed:Aug 1, 2019
Classes:5
DRAGGING TOMORROW INTO TODAY
DRAGGING TOMORROW INTO TODAY
Service Mark
Word
REGISTERED
Owner:
Serial:88517231
Filed:Jul 16, 2019
Classes:44
Registration:6937017
Registered:Dec 27, 2022
Goods & Services
Medical information services, namely, providing information relating to rare diseases, medicines, health conditions, and treatment options
DRAG TOMORROW INTO TODAY
DRAG TOMORROW INTO TODAY
Service Mark
Word
REGISTERED
Owner:
Serial:88517258
Filed:Jul 16, 2019
Classes:44
Registration:6937018
Registered:Dec 27, 2022
Goods & Services
Medical information services, namely, providing information relating to rare diseases, medicines, health conditions, and treatment options
88514434
88514434
Trademark
Design
REGISTERED
Owner:
Serial:88514434
Filed:Jul 15, 2019
Classes:5
Registration:6342347
Registered:May 4, 2021
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
SAREPTA
SAREPTA
Trademark
Word
REGISTERED
Owner:
Serial:88514961
Filed:Jul 15, 2019
Classes:5
Registration:6342349
Registered:May 4, 2021
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
VYONDYS
VYONDYS
Trademark
Word
REGISTERED
Owner:
Serial:88314190
Filed:Feb 25, 2019
Classes:5
Registration:6228735
Registered:Dec 22, 2020
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders
AQTIVIDE
AQTIVIDE
Trademark
Word
ABANDONED
Owner:
Serial:87910222
Filed:May 7, 2018
Classes:5
DYSTRIATE
DYSTRIATE
Trademark
Word
ABANDONED
Owner:
Serial:87910213
Filed:May 7, 2018
Classes:5
EXDYSYS
EXDYSYS
Trademark
Word
ABANDONED
Owner:
Serial:87910205
Filed:May 7, 2018
Classes:5
JEQLIVA
JEQLIVA
Trademark
Word
ABANDONED
Owner:
Serial:87910202
Filed:May 7, 2018
Classes:5
MYTRENT
MYTRENT
Trademark
Word
ABANDONED
Owner:
Serial:87910195
Filed:May 7, 2018
Classes:5
RYACLEV
RYACLEV
Trademark
Word
ABANDONED
Owner:
Serial:87910179
Filed:May 7, 2018
Classes:5
TAVICLA
TAVICLA
Trademark
Word
ABANDONED
Owner:
Serial:87910173
Filed:May 7, 2018
Classes:5
XACLIATE
XACLIATE
Trademark
Word
ABANDONED
Owner:
Serial:87910168
Filed:May 7, 2018
Classes:5
XEFLETE
XEFLETE
Trademark
Word
ABANDONED
Owner:
Serial:87910159
Filed:May 7, 2018
Classes:5
PMOPLUS
PMOPLUS
Trademark
Word
ABANDONED
Owner:
Serial:87864473
Filed:Apr 5, 2018
Classes:1
ROUTE 79
ROUTE 79
Service Mark
Word
REGISTERED
Owner:
Serial:87843046
Filed:Mar 21, 2018
Classes:36
Registration:5898015
Registered:Oct 29, 2019
Goods & Services
Providing educational scholarships and financial assistance for tuition and other educational expenses, books, educational supplies and educational equipment; administering monetary contributions for those in need
EXONDYS 51 ETEPLIRSEN INJECTION
EXONDYS 51 ETEPLIRSEN INJECTION
Service Mark
Combined
REGISTERED
Owner:
Serial:87656211
Filed:Oct 23, 2017
Classes:44
Registration:5490967
Registered:Jun 12, 2018
Goods & Services
"51 ETEPLIRSEN INJECTION"
SUPPORT, BY YOUR PATIENTS' SIDE
SUPPORT, BY YOUR PATIENTS' SIDE
Service Mark
Word
REGISTERED
Owner:
Serial:87468454
Filed:May 30, 2017
Classes:35, 36, 44
Registration:5835280
Registered:Aug 13, 2019
Goods & Services
Providing information about healthcare insurance plans, patient financial assistance, and patient reimbursement programs; Program for healthcare providers and patients to obtain information about payments for medication, medication insurance coverage, reimbursement, payer policies, and patient financial assistance; Healthcare insurance services including benefit verification services, insurance authorization support and information, and claims processing and appeal support in the nature of insurance claims administration; Providing patient financial assistance and financial administration of reimbursement programs; Business administration of pharmacy reimbursement programs and services; Business administration of patient reimbursement programs; program to provide prescription pharmaceuticals at reduced or no cost for those in need; counselling services, namely, providing information and counselling with respect to access to medical treatment and care; Providing health information; Providing access to pharmaceuticals in the nature of a patient assistance program to provide drugs at reduced or no cost to patients
EXONDYS 51 ETEPLIRSEN INJECTION
EXONDYS 51 ETEPLIRSEN INJECTION
Trademark
Combined
REGISTERED
Owner:
Serial:87175636
Filed:Sep 19, 2016
Classes:5
Registration:6059005
Registered:May 19, 2020
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; "51 ETEPLIRSEN INJECTION"
SAREPTASSIST
SAREPTASSIST
Service Mark
Combined
REGISTERED
Owner:
Serial:87175621
Filed:Sep 19, 2016
Classes:36, 44
Registration:5840066
Registered:Aug 20, 2019
Goods & Services
Providing information about healthcare insurance plans, patient financial assistance, and patient reimbursement programs; Program for healthcare providers and patients to obtain information about medication, medication insurance coverage, reimbursement, payer policies, and patient financial assistance; Healthcare insurance services including benefit verification services, insurance authorization support and information, and claims processing and appeal support; Patient financial assistance and reimbursement programs; Providing prescription pharmaceuticals at reduced or no cost for those in need; counselling services, namely, providing information and counselling with respect to access to medical treatment and care; Providing health information; Providing access to pharmaceuticals
SAREPTASSIST
SAREPTASSIST
Service Mark
Word
REGISTERED
Owner:
Serial:87175600
Filed:Sep 19, 2016
Classes:36, 44
Registration:5840065
Registered:Aug 20, 2019
Goods & Services
Providing information about healthcare insurance plans, patient financial assistance, and patient reimbursement programs; Program for healthcare providers and patients to obtain information about medication, medication insurance coverage, reimbursement, payer policies, and patient financial assistance; Healthcare insurance services including benefit verification services, insurance authorization support and information, and claims processing and appeal support; Patient financial assistance and reimbursement programs; Providing prescription pharmaceuticals at reduced or no cost for those in need; counselling services, namely, providing information and counselling with respect to access to medical treatment and care; Providing health information; Providing access to pharmaceuticals

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.

View our privacy policy